A study suggests that long-term use (over 4.5 years) of proton pump inhibitors (PPIs), common medications for acid reflux, may be associated with a 33% increased risk of developing dementia, though it does not establish causation. The research analyzed data from over 5,700 participants and highlights the need for further investigation and consultation with healthcare providers before making changes to medication routines.
A study suggests that long-term use (over 4.4 years) of proton pump inhibitors (PPIs) for heartburn may be associated with a 33% increased risk of developing dementia, though causation is not proven. Experts advise consulting doctors before making changes to medication routines, as prolonged use has also been linked to other health issues.
Dr. Martin Scurr explains that long-term use of proton pump inhibitors (PPIs) like lansoprazole, commonly prescribed for hiatus hernia and acid reflux, may be associated with an increased risk of dementia. Lifestyle changes and over-the-counter antacids are now considered the first-line treatment for reflux, with medication as a secondary option. Additionally, a reader seeks advice on persistent neck and shoulder pain after being misdiagnosed with polymyalgia rheumatica, prompting Dr. Scurr to suggest investigating wear and tear of the neck discs. Dr. Scurr also expresses concern over the inadequate funding for GPs, which may lead to a decline in patient care and the potential abandonment of GP care in favor of less trained healthcare professionals.
Over-the-counter heartburn medications known as proton pump inhibitors (PPIs) may increase the risk of dementia by 33% for those who take them for over four years, according to the Journal of Neurology. Integrative pharmacist Sherry Torkos recommends alternative approaches such as taking digestive enzymes, eating smaller meals, eating slower, and staying upright after meals to alleviate heartburn symptoms. It's important to consult a doctor before starting any new medication, especially during pregnancy.
A Danish cohort study conducted by researchers at Copenhagen University Hospital and Aarhus University has found significant correlations between the use of proton pump inhibitors (PPIs), commonly used antacid medications, and an increased risk of dementia. The study included over 1.9 million individuals aged 60 to 75 and found that PPI use was associated with a higher risk of all-cause dementia, particularly in those aged 60 to 69. However, the study does not establish causality, and it is unclear whether PPI use causes dementia or if there is a reverse causality or disruption in the gut-brain connection. Further research is needed to explore the underlying mechanisms and potential variations among dementia subtypes.
A new study published in the journal Neurology suggests a possible link between long-term use of heartburn medicine, specifically proton pump inhibitors (PPIs), and an increased risk of developing dementia. While the study shows a correlation, further research is needed to establish causality. Doctors are becoming more cautious in prescribing these medications and are encouraging patients to consider lifestyle changes, such as weight loss and dietary modifications, as alternative approaches to managing conditions like GERD and acid reflux. Quitting smoking is also recommended for gastrointestinal health.
A recent study suggests that long-term use of acid reflux medications, known as proton pump inhibitors (PPIs), may be linked to a higher risk of developing dementia. The study found that patients who took PPIs for over 4.4 years were 33% more likely to develop dementia compared to those who did not take the medications. However, more research is needed to fully understand the potential connection between long-term PPI use and dementia risk. Patients currently using acid reflux medications should consult with their healthcare provider before making any changes to their medication regimen.
Long-term use of proton pump inhibitors (PPIs), a type of acid reflux medication, may be associated with a 33% higher risk of developing dementia, according to a study published in the journal Neurology. The research, which included over 5,700 participants, found that those who took PPIs for more than 4.4 years had a higher risk of dementia compared to non-users. However, the study does not establish a direct causal relationship between PPIs and dementia, only a correlation. Further research is needed to confirm these findings and explore the reasons behind the potential link. It is advised that individuals taking PPIs consult with their doctors before making any changes to their medication regimen.
Long-term use of proton pump inhibitors (PPIs), commonly used to treat heartburn and acid reflux, may be associated with a higher risk of dementia, according to a study published in the journal Neurology. The study found that individuals aged 45 and above who took PPIs for over four years had a 33% higher risk of developing dementia compared to those who did not take the drugs. However, the study only shows an association and does not prove causation. More research is needed to confirm the findings and understand the possible link between long-term PPI use and dementia.
